Glomerular podocyte dysfunction in inherited renal tubular disease.
Huang LM, Mao JH.
World J Pediatr. 2021 Jun;17(3):227-233. doi: 10.1007/s12519-021-00417-0. Epub 2021 Feb 24.
Snakebite nephropathy.
Sitprija V.
Nephrology (Carlton). 2006 Oct;11(5):442-8. doi: 10.1111/j.1440-1797.2006.00599.x.
The glomerulo-tubular junction: a target in renal diseases.
Lindop GB, Gibson IW, Downie TT, Vass D, Cohen EP.
J Pathol. 2002 May;197(1):1-3. doi: 10.1002/path.1087.
The role of CDX2 in renal tubular lesions during diabetic kidney disease.
Liu H, Yan R, Liang L, Zhang H, Xiang J, Liu L, Zhang X, Mao Y, Peng W, Xiao Y, Zhang F, Zhou Y, Shi M, Wang Y, Guo B.
Aging (Albany NY). 2021 Feb 17;13(5):6782-6803. doi: 10.18632/aging.202537. Epub 2021 Feb 17.
Tubular lipidosis: epiphenomenon or pathogenetic lesion in human renal disease?
Ong AC, Moorhead JF.
Kidney Int. 1994 Mar;45(3):753-62. doi: 10.1038/ki.1994.100.
The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis.
Hong S, Healy H, Kassianos AJ.
Front Immunol. 2020 Sep 23;11:578952. doi: 10.3389/fimmu.2020.578952. eCollection 2020.
Transient renal dysfunction with reversible splenial lesion.
Watanabe T, Matsuda T, Kitagata R, Tajima I, Ono H, Hirano K, Shirai M, Endoh A, Hongo T.
Pediatr Int. 2014 Oct;56(5):e68-71. doi: 10.1111/ped.12412.
Glomerular tubular reflux--a morphologic renal lesion associated with the hepatorenal syndrome.
Kanel GC, Peters RL.
Hepatology. 1984 Mar-Apr;4(2):242-6. doi: 10.1002/hep.1840040212.
Nephrogenic adenoma.
Amin W, Parwani AV.
Pathol Res Pract. 2010 Oct 15;206(10):659-62. doi: 10.1016/j.prp.2010.06.001. Epub 2010 Jul 8.
Clinicopathologic Features of IgG4-Related Kidney Disease.
Buglioni A, Jenkins SM, Nasr SH, Zhang P, Gibson IW, Alexander MP, Herrera Hernandez LP, Fidler ME, Takahashi N, Hogan MC, Cornell LD.
Kidney Int Rep. 2024 May 15;9(8):2462-2473. doi: 10.1016/j.ekir.2024.05.011. eCollection 2024 Aug.
